Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03342729
Other study ID # IRB #17-000137
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 1, 2017
Est. completion date March 15, 2018

Study information

Verified date December 2019
Source University of California, Los Angeles
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The Aging Mastery Program® (AMP) is designed to inform, encourage, and support older adults as they take steps to improve their lives and stay engaged in their communities. The program incorporates evidence-informed materials, expert speakers, group discussion, peer support, and small rewards to give participants the skills and tools they need to achieve measurable improvements in managing their health, remaining economically secure, and contributing actively to society. L.A. CAPRA in partnership with the National Council on Aging, City of Los Angeles and the Los Angeles County Department of Aging will evaluate the effectiveness of the AMP program across 5 community-based senior sites. The overall objective of the proposed study is to evaluate the effectiveness of AMP program on improving the health and well-being of older adults using a randomized wait-list controlled trial.


Description:

The Aging Mastery ProgramĀ® (AMP) offers community-based organizations a clear path to engage older adults and address the physical, financial, and emotional wellness of older adults. First piloted nationally in five senior centers, AMP incorporates evidence-based materials, expert speakers, group discussion, and peer support to give participants the skills and tools they need to achieve measurable improvements in managing their health and remaining economically secure. The program aims to empower seniors to make and maintain small, impactful changes to their behaviors to live a healthier, happier, and more secure life. AMP has been field-tested in various rural and urban setting, senior centers, and across an ethnically diverse middle-aged and older adult population, reaching almost 6,000 since 2013. Currently, the program is being evaluated through a quasi-experimental study in New York State and under consideration as an evidence-based program.

The National Council on Aging study team will train six program leads from the City of Los Angeles Department of Aging and Los Angeles Area on Aging to implement Aging Mastery ProgramĀ® (AMP). The intervention will consist of a 10-week series held once-a-week for an hour and half (90 minutes). It will be group-based and led by trained facilitators and designated expert speakers in a community-based setting (senior centers). The program reviews 10 central areas of aging (1) navigating longer lives, (2) physical activity, (3) sleep, (4) healthy eating and hydration, (5) financial security, (6) medication management, (7) advance care planning, (8) healthy relationships, (9) falls prevention, and (10) community engagement. The intervention is based in social cognitive theory and attribution retraining and incorporates elements such as verbal persuasion, goal setting, problem solving, and attribution retraining techniques that encourage students to adopt controllable and unstable explanations.

Study Participants (N=200 or n=40/site) will be recruited from 5 study sites to participate in the Aging Mastery Program. UCLA study personnel will be on-site to consent older adults to participate in the evaluation of intervention and take part of baseline and post-intervention assessments. Upon signing the consent, study staff will collect self-administered baseline data (measures and measurement tools --i.e. Patient Information Survey, PROMIS and Patient Activation Survey (PAM) from all participants (n=200). After baseline data has been collected, participants will be randomized and assigned to either the immediate intervention groups (n=100 intervention) or the wait-list control (n=100). At each site, forty participants will be in the intervention group and 40 will be in wait-list control. Following the 10-week Aging Mastery ProgramĀ®, post-intervention assessment (measures and measurement tools --i.e. Patient Information Survey, Patient Satisfaction, PROMIS and PAM) will be administered. During the data collection sessions, study staff will go to community sites and collect post-treatment self-reported assessment


Recruitment information / eligibility

Status Completed
Enrollment 180
Est. completion date March 15, 2018
Est. primary completion date March 15, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 50 Years to 100 Years
Eligibility Inclusion Criteria:

1. Available to attend the baseline and post-treatment data collection session and subsequent weekly intervention sessions

2. Available to speak and understand English

3. Plans to be living in the region during the next 6 months

4. Has cognitive ability to provide informed consent to participate

Exclusion Criteria:

1. Cannot Speak or Communicate well in English

2. Unavailable to attend the baseline data collection session and subsequent weekly intervention sessions

3. Plans to move away from the region during the next 6 months

4. Lacks cognitive ability to provide informed consent to participate

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Intervention
Participants receive the AMP 10-week program immediately
Control
Participants will not received the AMP 10-week program immediately, rather will wait 3-months

Locations

Country Name City State
United States Antelope Valley Senior Center Lancaster California
United States Freda Mohr Multipurpose Center Los Angeles California
United States Potrero Heights Community Center Montebello California
United States San Pedro Service Center San Pedro California
United States Sherman Oaks East Valley Adult Center Sherman Oaks California

Sponsors (4)

Lead Sponsor Collaborator
University of California, Los Angeles City of Los Angeles Department of Aging, Los Angeles County Area Agency on Aging, The National Council on Aging

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Improvements in health and well-being Patient self-reported questionnaire PROMIS scale; SF-16 Pre-intervention (baseline) and questions will be repeated again 10-weeks after the baseline (for waitlist control/for those in class immediately after the class) as a Post-intervention.
Primary Improvements in Patient Activation Patient self-reported questionnaire PAM scale Pre-intervention (baseline) and questions will be repeated again 10-weeks after the baseline (for waitlist control/for those in class immediately after the class) as a Post-intervention.
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1